News articles

News article list

• World’s first gene editing therapy for blood disorder to be available to hundreds of patients in England

  Patients in England with severe beta-thalassaemia will be amongst the first in Europe to benefit from one-time gene therapy exagamglogene autotemcel.

• 14,000 women at risk of fractures after the menopause to benefit from bone disease drug

  Over 14,000 people to benefit after NICE published final guidance recommending abaloparatide as an option for treating osteoporosis after menopause, if there is a very high risk of fracture.

• NICE disappointed companies unwilling to offer fair price to make Enhertu available for advanced breast cancer

  Daiichi Sankyo and partner company AstraZeneca have been unwilling to offer a price that would enable NICE to recommend Enhertu as cost effective for the NHS in final guidance published today.

• New clot-busting drug recommended by NICE set to save NHS £millions

  Giving a new clot-busting drug to people who have had a stroke could help save the NHS millions of pounds.

• More than 40,000 people could benefit after NICE recommends new ‘take at home’ pill for advanced prostate cancer

  Thousands of people could benefit from a new oral hormone therapy for advanced hormone sensitive prostate cancer.

• NICE recommends digital technology to help diagnose ADHD in children and young people

  A digital technology that will help healthcare professionals provide a quicker diagnosis to people with attention deficit hyperactivity disorder (ADHD) can be used by the NHS, NICE has said in draft guidance.